immune cells

Health outlets are highlighting an mRNA vaccine being developed for melanoma, the deadliest form of skin cancer. The approach uses the same mRNA technology proven in COVID-19 vaccines, training the immune system to recognize and attack tumor cells. WVU Medicine shared the update, and the item is drawing attention as trials of personalized cancer vaccines continue to advance globally.

Researchers at Washington University School of Medicine report that blocking the route immune cells use to enter the brain can limit neurodegeneration. The findings suggest a potential therapeutic strategy for diseases like Alzheimer's and other neurodegenerative conditions, by preventing inflammatory immune cells from crossing into brain tissue and damaging neurons.

Researchers at UMass Chan Medical School report that lupus patients treated with CAR T cell therapy have remained free of disease flares two years after receiving the one-time cell-based treatment. The therapy, originally developed for blood cancers, reprograms a patient's own immune cells, and the latest follow-up data suggest it may offer lasting remission in autoimmune disease.

UConn Health has announced the launch of a new CAR-T cell therapy program, a form of immunotherapy that engineers a patient's own immune cells to fight cancer. The initiative brings an advanced, personalised cancer treatment to the Connecticut institution, expanding access for patients in the region who previously had to travel elsewhere for such therapy.

Yale School of Medicine is highlighting advances in CAR-T therapy, a treatment that engineers a patient's immune cells to fight disease. Originally developed for blood cancers, the approach is now being adapted and studied for autoimmune conditions, marking a significant expansion of its potential use in medicine.